Lantheus Holdings, Inc. LNTH revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Lantheus Holdings, Inc. reported revenue across 11 products and services; the largest, Product, was $1.51B (-1.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$1.51Bshare n/a-1.1% yoy
- PYLARIFY$989Mshare n/a-6.5% yoy
- Radiopharmaceutical Oncology$989Mshare n/a-6.5% yoy
- Total Precision Diagnostics$493Mshare n/a+12.7% yoy
- Definity$330Mshare n/a+3.9% yoy
- Techne Lite$86.8Mshare n/a-9.1% yoy
- Strategic Partnerships And Other$59.4Mshare n/a+55.5% yoy
- Neuraceq$51.4Mshare n/ano prior
- +3 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$1.46B94.6%-1.7% yoy
- Outside the United States$82.7M5.4%+68.1% yoy
Members sum to the consolidated $1.54B for this period.
- Product$370Mshare n/a+0.8% yoy
- PYLARIFY$241Mshare n/a-6.5% yoy
- Oncology$241Mshare n/a-6.5% yoy
- Definity$84.6Mshare n/a+6.8% yoy
- Cardiology$84.6Mshare n/a+6.8% yoy
- Neurology$35.4Mshare n/ano prior
- +4 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.